NASDAQ:ACRX
Delisted

Acelrx Pharmaceuticals Stock News

etoro logo Buy ACRX
*Your capital is at risk
$0.86
+0 (+0%)
At Close: Apr 08, 2024
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an averag
Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. AcelRx
AcelRx's 2Q22 Earnings Release and Call provided little tangible news. However, it becomes more and more obvious that ACRX's management is fully shifting the focus from commercial DSUVIA to launching
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Twin Vee Powercats Co. (NASDAQ: VEEE) shares cl
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. Unity Biotechnology, Inc. (NYSE: UBX) jumped 70% to $1.4492 af
Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. TOP Financial Group Limited (
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Raffi Asadorian - CFO Vincent Angotti - CEO Pamela Palmer - Chief Medical O

AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Misses Revenue Estimates

09:35pm, Thursday, 11'th Aug 2022 Zacks Investment Research
AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 0% and 5%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 0% and 5%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. T2 Biosystems, Inc. (NASDAQ: TTOO) s

Why Is AcelRx (ACRX) Stock up 26% Today?

11:04am, Thursday, 11'th Aug 2022
Source: Shutterstock AcelRx Pharmaceuticals (NASDAQ: ACRX ) stock is seeing major gains on Thursday after announcing a presentation for the upcoming Plastic Surgery: The Meeting 2022. That meeting is
The stock price of AcelRx Pharmaceuticals (ACRX) skyrocketed over 70% pre-market today. This is why.

Cronos Group (CRON) Reports Q2 Loss, Lags Revenue Estimates

01:45pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Cronos (CRON) delivered earnings and revenue surprises of 0% and 16.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares rose 46% to $6.98 in pre-market trading after jumping around 46% on Friday. The company recently said it expects unaudited comprehen
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE